Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Exelixis Inc
(NQ:
EXEL
)
23.73
USD
-0.05 (-0.23%)
Official Closing Price
Updated: 7:49 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Exelixis Inc
< Previous
1
2
3
4
5
6
7
8
9
...
79
80
Next >
Notable Monday Option Activity: ADI, EXEL, KBH
January 11, 2021
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Analog Devices Inc (ADI), where a total volume of 11,041 contracts has been traded...
Tags
Stocks
From
Market News Video
Good News, Bad News Day
January 11, 2021
Today the stock market woke up to the risks both political and economic facing the Land of the Free and the Home of the Brave after reflecting over the weekend.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Exelixis Announces Preliminary Fourth Quarter and Full Year 2020 Financial Results, Provides 2021 Financial Guidance, and Outlines Key Priorities and Anticipated Milestones For 2021
January 10, 2021
Exelixis, Inc. (Nasdaq: EXEL) today announced its preliminary unaudited financial results for the fourth quarter and full year 2020, provided financial guidance for full year 2021, and delivered an...
From
Business Wire News Releases
3 Top Biotech Picks for 2021
January 10, 2021
One big biotech and two small biotechs that share a common denominator: Great growth prospects.
Tags
NVAX
EXEL
BMY
From
Motley Fool
5 Value Stocks That Will Make You Richer in 2021
January 09, 2021
Bargains are plentiful for value investors in the new year.
Tags
EXEL
Market News
WBA
From
Motley Fool
Interesting EXEL Put And Call Options For March 19th
January 07, 2021
Investors in Exelixis Inc (EXEL) saw new options begin trading today, for the March 19th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time...
Tags
Stocks
From
Market News Video
Exelixis to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021
January 04, 2021
Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will provide a corporate overview at the virtual 39th Annual J.P....
From
Business Wire News Releases
Why Calithera Biosciences Stock Is Plunging Today
January 04, 2021
The company reported negative results from a clinical trial.
Tags
EXEL
Market News
CALA
From
Motley Fool
3 Healthcare Stocks That Are Screaming Buys in 2021
December 31, 2020
Here's your prescription for huge returns in the upcoming year.
Tags
EXEL
JUSHF
Market News
From
Motley Fool
Should Investors Be Watching These Top Biotech Stocks Next Week? 3 To Consider
December 30, 2020
Tags
Market News
From
Stockmarket.com
3 Beaten-Down Growth Stocks That Can Soar in 2021
December 23, 2020
These high-growth companies are big-time bargains for opportunistic investors.
Tags
VRTX
PING
Market News
From
Motley Fool
Should Investors Consider This Biotech Takeover Target?
December 21, 2020
Getting in on the extensive merger and acquisition game of large pharmaceutical companies is the ultimate endgame for Exelixis, a biotech that already boasts an established cancer-focused product...
Tags
LLY
NVS
ALXN
From
Motley Fool
Exelixis Announces Cabozantinib Significantly Improved Progression-Free Survival in COSMIC-311 Phase 3 Pivotal Trial in Patients with Previously Treated Radioiodine-Refractory Differentiated Thyroid C
December 21, 2020
Exelixis, Inc. (NASDAQ: EXEL) today announced that COSMIC-311, the phase 3 pivotal trial evaluating cabozantinib (CABOMETYX®) versus placebo in patients with radioiodine-refractory differentiated...
From
Business Wire News Releases
3 Top Biotech Stocks to Buy Right Now
December 19, 2020
Each of them should enjoy strong sales growth in 2021 and beyond.
Tags
NVAX
EXEL
BMY
From
Motley Fool
XWPharma Names Michael M. Morrissey, PhD to Board of Directors
December 16, 2020
Appointment Adds Senior Biopharma Operational Expertise to Board Oversight as Company Advances its Pipeline of Novel CNS Therapeutics in Research and Clinical Development
From
GlobeNewswire News Releases
No Security
December 14, 2020
Value Line, which usually says to buy recommended stocks for growth and income, caused a shock wave today.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Add Up The Parts: PBE Could Be Worth $77
December 14, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Pearl Harbor Day
December 07, 2020
With new corona-virus lockdowns, the price of oil has fallen.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Exelixis In-Licenses Aurigene’s Novel CDK7 Inhibitor and Files Investigational New Drug Application for Phase 1 Clinical Trial in Advanced Solid Tumors
December 07, 2020
Exelixis, Inc. (Nasdaq: EXEL) and Aurigene today announced that Exelixis has exercised its exclusive option for Aurigene’s novel CDK7 inhibitor under the companies’ July 2019 agreement. Exelixis has...
From
Business Wire News Releases
Calithera Biosciences: An Under The Radar Opportunity
December 07, 2020
Calithera is a high-risk, high reward speculative investment addressing high unmet and under-served needs markets, with a lower bar data threshold to meet. Calithera has an important near-term catalyst...
Tags
Stocks / Equities
Healthcare
Pharma/Biotech
From
Blogs - TalkMarkets
Sometimes Bad News Is Good
December 04, 2020
The horrible unemployment data today increases the odds that a renewed stimulus bill will be crafted before Biden takes the helm.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Should Investors Buy Moderna Stock for Its Coronavirus Vaccine?
December 03, 2020
Don't forget about the biotech's long-term valuation.
Tags
Market News
BMRN
SGEN
From
Motley Fool
Problems To Come
December 03, 2020
Perhaps the biggest risk for bulls is the likelihood of higher taxes on capital gains and inheritances being planned by the future Biden Administration.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Exelixis In-Licenses Iconic Therapeutics’ Tissue Factor-Targeting Antibody-Drug Conjugate Ahead of Planned Investigational New Drug Application
December 02, 2020
Exelixis, Inc. (Nasdaq: EXEL), Iconic Therapeutics, Inc. (Iconic) and Zymeworks Inc. (NYSE:ZYME) today announced that Exelixis has exercised its exclusive option for Iconic’s lead oncology...
From
Business Wire News Releases
Exelixis Announces Partner Takeda Receives Approval in Japan for CABOMETYX® (cabozantinib) for the Treatment of Unresectable Hepatocellular Carcinoma That Has Progressed After Prior Systemic Therapy
November 27, 2020
Exelixis, Inc. (NASDAQ: EXEL) today announced that Takeda Pharmaceutical Company Limited (Takeda), its partner responsible for the clinical development and commercialization of CABOMETYX®...
From
Business Wire News Releases
Got $50? 4 Smart Stocks to Buy Into Right Now
November 27, 2020
You don't need to start with a fortune to build wealth on Wall Street.
Tags
AUY
SIRI
Market News
From
Motley Fool
Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in December
November 23, 2020
Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the company’s management team will participate in fireside chats at the following virtual investor conferences in December:
From
Business Wire News Releases
EQAL's Holdings Imply 11% Gain Potential
November 13, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
12 Healthcare Stocks Moving In Thursday's After-Market Session
November 05, 2020
Gainers Chembio Diagnostics (NASDAQ:CEMI) shares moved upwards by 11.95% to $4.96 during Thursday's after-market session. ...
Tags
After/Hours Center
CBAY
Benzinga
From
Benzinga
Exelixis Announces Third Quarter 2020 Financial Results and Provides Corporate Update
November 05, 2020
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of 2020 and provided an update on progress toward fulfilling its key corporate objectives, as well as commercial and...
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
79
80
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.